CME Group (NASDAQ:CME) had its price target hoisted by analysts at Raymond James from $225.00 to $230.00 in a research note issued to investors on Thursday, Stock Target Advisor reports. The firm presently has an “outperform” rating on the financial services provider’s stock. Raymond James’ price objective suggests a potential upside of 5.96% from the stock’s current price.
Other research analysts have also issued reports about the company. Berenberg Bank reissued a “hold” rating on shares of CME Group in a research report on Wednesday, September 15th. Morgan Stanley decreased their target price on CME Group from $229.00 to $217.00 and set an “equal weight” rating for the company in a research report on Friday, October 8th. Piper Sandler reaffirmed a “buy” rating and issued a $230.00 target price on shares of CME Group in a research report on Friday, October 1st. Atlantic Securities raised CME Group from a “neutral” rating to an “overweight” rating and set a $230.00 target price for the company in a research report on Tuesday, September 14th. Finally, TheStreet lowered CME Group from a “b” rating to a “c+” rating in a research report on Wednesday, August 18th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus target price of $212.71.
CME stock opened at $217.06 on Thursday. The stock has a 50-day moving average price of $198.35 and a 200-day moving average price of $206.58. CME Group has a 1-year low of $146.89 and a 1-year high of $221.82. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $77.95 billion, a PE ratio of 40.57 and a beta of 0.43.
In related news, Director Martin J. Gepsman sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, September 13th. The stock was sold at an average price of $188.53, for a total value of $188,530.00. Following the transaction, the director now owns 24,468 shares in the company, valued at $4,612,952.04. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Sean Tully sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 24th. The shares were sold at an average price of $200.20, for a total value of $1,001,000.00. Following the completion of the transaction, the insider now owns 23,479 shares in the company, valued at approximately $4,700,495.80. The disclosure for this sale can be found here. Insiders sold a total of 11,947 shares of company stock worth $2,419,755 in the last 90 days. Company insiders own 0.30% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the company. RE Advisers Corp bought a new position in shares of CME Group in the second quarter worth $38,000. Capital Analysts LLC increased its holdings in shares of CME Group by 370.0% in the first quarter. Capital Analysts LLC now owns 188 shares of the financial services provider’s stock worth $38,000 after purchasing an additional 148 shares during the period. Glassman Wealth Services increased its holdings in shares of CME Group by 54.0% in the second quarter. Glassman Wealth Services now owns 191 shares of the financial services provider’s stock worth $41,000 after purchasing an additional 67 shares during the period. Eagle Bay Advisors LLC bought a new position in shares of CME Group in the second quarter worth $52,000. Finally, Patriot Financial Group Insurance Agency LLC increased its holdings in shares of CME Group by 32.1% in the second quarter. Patriot Financial Group Insurance Agency LLC now owns 317 shares of the financial services provider’s stock worth $67,000 after purchasing an additional 77 shares during the period. 86.19% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Company Profile
CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.
See Also: What is a Reverse Stock Split?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.